Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Prevention
Interventions: DRUG: Metformin|DRUG: Placebo
Sponsor: University of Arizona
Collaborators: National Cancer Institute (NCI)